Sarepta Therapeutics, Inc. (SRPT) Social Stream



Sarepta Therapeutics, Inc. (SRPT): $130.89

-0.28 (-0.21%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SRPT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

SAREPTA THERAPEUTICS INC (SRPT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering SAREPTA THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 17 $160 $90 $127.25 $122.69 3.72%
2021-12-26 16 $160 $90 $127.076 $122.69 3.57%
2022-01-05 16 $160 $90 $126.538 $122.69 3.14%
2022-01-11 13 $160 $90 $128.083 $122.69 4.4%
2022-01-19 14 $160 $90 $128.083 $122.69 4.4%
2022-01-26 14 $160 $92 $126.833 $122.69 3.38%
2022-02-09 14 $160 $71 $125.083 $122.69 1.95%
2022-03-04 13 $150 $71 $121.909 $122.69 -0.64%
2022-03-07 13 $150 $80 $122.727 $122.69 0.03%
2022-03-16 13 $150 $80 $123 $122.69 0.25%
2022-04-04 13 $150 $80 $124.3 $122.69 1.31%
2022-04-12 13 $150 $77 $124 $122.69 1.07%
2022-04-20 13 $150 $77 $124.2 $122.69 1.23%
2022-05-09 13 $150 $77 $124.1 $122.69 1.15%
2022-05-13 13 $150 $77 $124.6 $122.69 1.56%
2022-05-18 13 $150 $74 $124.3 $122.69 1.31%
2022-05-24 14 $155 $74 $127.09 $122.69 3.59%
2022-06-22 13 $155 $74 $127.09 $122.69 3.59%
2022-07-25 13 $155 $80 $126.272 $122.69 2.92%
2022-07-29 13 $162 $80 $127.363 $122.69 3.81%
2022-08-03 13 $162 $80 $127.583 $122.69 3.99%
2022-08-04 13 $162 $100 $132.076 $122.69 7.65%
2022-08-09 13 $182 $100 $133.769 $122.69 9.03%
2022-08-13 13 $182 $100 $134.923 $122.69 9.97%
2022-09-06 13 $182 $100 $136.461 $122.69 11.22%
2022-09-07 13 $182 $100 $137.461 $122.69 12.04%
2022-09-14 13 $182 $114 $140.153 $122.69 14.23%
2022-10-03 12 $182 $114 $141.416 $122.69 15.26%
2022-10-12 12 $182 $114 $141.916 $122.69 15.67%
2022-10-20 12 $182 $114 $143.5 $122.69 16.96%
2022-10-21 12 $182 $114 $144 $122.69 17.37%
2022-11-25 12 $190 $114 $146.153 $122.69 19.12%
2022-12-02 12 $190 $114 $146.846 $122.69 19.69%
2022-12-19 13 $190 $114 $147.642 $122.69 20.34%
2022-12-22 14 $190 $114 $148.466 $122.69 21.01%
2022-12-29 14 $190 $114 $150.066 $122.69 22.31%
2023-01-04 15 $190 $114 $151.533 $122.69 23.51%
2023-01-10 15 $190 $114 $151.666 $122.69 23.62%
2023-01-16 15 $190 $122 $152.4 $122.69 24.22%
2023-02-27 15 $190 $122 $153.4 $122.69 25.03%
2023-03-01 16 $190 $122 $154.933 $122.69 26.28%
2023-03-02 16 $226 $122 $169 $122.69 37.75%
2023-03-09 16 $226 $122 $172.533 $122.69 40.63%

The Trend in the Analyst Price Target


SRPT's average price target has moved down $25.42 over the prior 33 months.

Over the past 49 weeks, SRPT's average upside potential has been 33.98%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-12 13 150 77 124.000 82.34 50.6%
2022-08-13 13 182 100 134.923 109.00 23.78%
2022-09-07 13 182 100 137.461 112.90 21.75%
2022-12-22 14 190 114 148.466 132.13 12.36%
2023-01-10 15 190 114 151.666 119.13 27.31%

SRPT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.38 12 2 2 0 0 16

The Trend in the Broker Recommendations


Over the past 13 months, SRPT's average broker recommendation rating improved by 0.05.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SRPT as an investment opportunity.

  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SAREPTA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 485.36% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SAREPTA THERAPEUTICS INC's average analyst price target is greater than 4303.4% of them.
  • SAREPTA THERAPEUTICS INC's number of analysts covering the stock is higher than 4170.81% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, SAREPTA THERAPEUTICS INC's variance in analysts' estimates is lower than -2987.33% of them.

Stocks similar to SAREPTA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are REGN, BMY, and RPRX.

What is the outlook for SRPT? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7702 seconds.